Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 4 studies | 25% ± 3% |
Insufficient scRNA-seq data for expression of SLC51A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 184.79 | 245 / 245 | 99% | 3.83 | 498 / 502 |
breast | 100% | 180.68 | 458 / 459 | 96% | 2.57 | 1071 / 1118 |
liver | 100% | 3122.11 | 226 / 226 | 95% | 29.13 | 385 / 406 |
kidney | 100% | 341.38 | 89 / 89 | 90% | 2.98 | 810 / 901 |
uterus | 100% | 146.45 | 170 / 170 | 90% | 4.81 | 411 / 459 |
bladder | 100% | 144.14 | 21 / 21 | 87% | 2.44 | 438 / 504 |
thymus | 100% | 203.08 | 652 / 653 | 86% | 1.86 | 520 / 605 |
esophagus | 100% | 153.92 | 1443 / 1445 | 85% | 2.89 | 155 / 183 |
lung | 99% | 232.13 | 575 / 578 | 82% | 3.14 | 949 / 1155 |
brain | 92% | 89.53 | 2439 / 2642 | 89% | 1.57 | 626 / 705 |
intestine | 100% | 1024.26 | 966 / 966 | 71% | 1.86 | 373 / 527 |
skin | 99% | 229.38 | 1786 / 1809 | 67% | 1.16 | 318 / 472 |
stomach | 99% | 112.28 | 354 / 359 | 67% | 1.46 | 193 / 286 |
ovary | 100% | 310.08 | 180 / 180 | 66% | 1.38 | 282 / 430 |
adrenal gland | 100% | 914.91 | 258 / 258 | 64% | 7.26 | 148 / 230 |
pancreas | 79% | 61.00 | 259 / 328 | 81% | 1.77 | 144 / 178 |
adipose | 100% | 197.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 364.32 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.99 | 1 / 1 |
blood vessel | 99% | 139.75 | 1324 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 704.00 | 908 / 929 | 0% | 0 | 0 / 0 |
muscle | 97% | 115.78 | 781 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 146.24 | 828 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 4.80 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 79% | 1.97 | 23 / 29 |
eye | 0% | 0 | 0 / 0 | 29% | 0.35 | 23 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015721 | Biological process | bile acid and bile salt transport |
GO_0032782 | Biological process | bile acid secretion |
GO_0055085 | Biological process | transmembrane transport |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005215 | Molecular function | transporter activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0015125 | Molecular function | bile acid transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC51A |
Protein name | Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) Solute carrier family 51 subunit alpha |
Synonyms | OSTA |
Description | FUNCTION: Essential component of the Ost-alpha/Ost-beta complex, a heterodimer that acts as the intestinal basolateral transporter responsible for bile acid export from enterocytes into portal blood . Efficiently transports the major species of bile acids (taurocholate) . Taurine conjugates are transported more efficiently across the basolateral membrane than glycine-conjugated bile acids (By similarity). Can also transport steroids such as estrone 3-sulfate and dehydroepiandrosterone 3-sulfate, therefore playing a role in the enterohepatic circulation of sterols . Able to transport eicosanoids such as prostaglandin E2 (By similarity). . |
Accessions | Q86UW1 ENST00000296327.10 F8WBV2 C9J2I5 H7C351 ENST00000428985.1 ENST00000416660.1 ENST00000442203.1 H7C3V2 ENST00000415111.1 |